Skip Nav Destination
Issues
1 September 2021
-
Cover Image
Cover Image
The cover image is adapted from Figure 2 in the article “Genetic analysis of functional rare germline variants across nine cancer types from an electronic health record linked biobank,” by Shivakumar and colleagues. The figure shows a waterfall plot with pathways (x-axis) that were significantly associated with cancer (y-axis) and were replicated in either replication or TCGA. Rare variants play an essential role in the etiology of cancer. In this study, the authors aimed to characterize rare germline variants that impact the risk of cancer. The authors conducted an exome-wide rare-variant analysis to find novel genes and pathways associated across nine cancers. They replicated many genes and pathways that were known to be associated with cancers. Some of the significant genes in this study were linked to the pathways that were also significantly associated with cancers, which could potentially aid in understanding the mechanism of gene action. The genes and pathways discovered in this study could eventually be used to screen for high-risk cancer patients and personalized therapy. For more information, see the article beginning on page 1681. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1055-9965
EISSN 1538-7755
Highlights
Commentaries
Cancer Surveillance Research
Research Articles
Circulating Fatty Acids Associated with Advanced Liver Fibrosis and Hepatocellular Carcinoma in South Texas Hispanics
Jingjing Jiao; Suet-Ying Kwan; Caroline M. Sabotta; Honami Tanaka; Lucas Veillon; Marc O. Warmoes; Philip L. Lorenzi; Ying Wang; Peng Wei; Ernest T. Hawk; Jose Luis Almeda; Joseph B. McCormick; Susan P. Fisher-Hoch; Laura Beretta
Genital Powder Use and Risk of Epithelial Ovarian Cancer in the Ovarian Cancer in Women of African Ancestry Consortium
Colette P. Davis; Elisa V. Bandera; Traci N. Bethea; Fabian Camacho; Charlotte E. Joslin; Anna H. Wu; Alicia Beeghly-Fadiel; Patricia G. Moorman; Evan R. Myers; Heather M. Ochs-Balcom; Lauren C. Peres; Will T. Rosenow; Veronica W. Setiawan; Lynn Rosenberg; Joellen M. Schildkraut; Holly R. Harris
Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer
Michael C.J. Quinn; Karen McCue; Wei Shi; Sharon E. Johnatty; Jonathan Beesley; Andrew Civitarese; Tracy A. O'Mara; Dylan M. Glubb; Jonathan P. Tyrer; Sebastian M. Armasu; Jue-Sheng Ong; Puya Gharahkhani; Yi Lu; Bo Gao; Ann-Marie Patch; Peter A. Fasching; Matthias W. Beckmann; Diether Lambrechts; Ignace Vergote; Digna R. Velez Edwards; Alicia Beeghly-Fadiel; Javier Benitez; Maria J. Garcia; Marc T. Goodman; Thilo Dörk; Matthias Dürst; Francesmary Modugno; Kirsten Moysich; Andreas du Bois; Jacobus Pfisterer; Klaus Bauman; Beth Y. Karlan; Jenny Lester; Julie M. Cunningham; Melissa C. Larson; Bryan M. McCauley; Susanne K. Kjaer; Allan Jensen; Claus K. Hogdall; Estrid Hogdall; Joellen M. Schildkraut; Marjorie J. Riggan; Andrew Berchuck; Daniel W. Cramer; Kathryn L. Terry; Line Bjorge; Penelope M. Webb; Michael Friedlander; Tanja Pejovic; Melissa Moffitt; Rosalind Glasspool; Taymaa May; Gabrielle E.V. Ene; David G. Huntsman; Michelle Woo; Michael E. Carney; Samantha Hinsley; Florian Heitz; Sian Fereday; Catherine J. Kennedy; Stacey L. Edwards; Stacey J. Winham; Anna deFazio; Paul D.P. Pharoah; Ellen L. Goode; Stuart MacGregor; Georgia Chenevix-Trench; for the AGO Study Group
HPV-Induced Oropharyngeal Squamous Cell Carcinomas in Brazil: Prevalence, Trend, Clinical, and Epidemiologic Characterization
Raiany Santos Carvalho; Cristovam Scapulatempo-Neto; Maria Paula Curado; Renato de Castro Capuzzo; Fernanda Marsico Teixeira; Rafael Cardoso Pires; Maria Thereza Cirino; Jessica Cambrea Joaquim Martins; Isabella Almeida Oliveira da Silva; Marco Antonio Oliveira; Marcel Watanabe; Adeylson Guimarães Ribeiro; Gisele Caravina de Almeida; Rui Manuel Reis; Ricardo Ribeiro Gama; André Lopes Carvalho; Ana Carolina de Carvalho
Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular Markers
Gabrielle Jongeneel; Marjolein J.E. Greuter; Natalia Kunst; Felice N. van Erning; Miriam Koopman; Jan P. Medema; Louis Vermeulen; Jan N.M. Ijzermans; Geraldine R. Vink; Cornelis J.A. Punt; Veerle M.H. Coupé
Null Results in Brief
Low-Fat Dietary Modification and Risk of Ductal Carcinoma In Situ of the Breast in the Women's Health Initiative Dietary Modification Trial
Rita Peila; Rowan Chlebowski; JoAnn E. Manson; Tracy E. Crane; Dorothy S. Lane; Nazmus Saquib; Aladdin H. Shadyab; Fred K. Tabung; Ana Barac; Zhenzhen Zhang; Kathy Pan; Sylvia Wassertheil-Smoller; Thomas E. Rohan
Association between Human Polyomaviruses and Keratinocyte Carcinomas: A Prospective Cohort Study
Rossybelle P. Amorrortu; Yayi Zhao; Jane L. Messina; Michael J. Schell; Neil A. Fenske; Basil S. Cherpelis; Vernon K. Sondak; Anna R. Giuliano; Michael Pawlita; Sandrine McKay-Chopin; Tarik Gheit; Tim Waterboer; Massimo Tommasino; Dana E. Rollison
Letter to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.